
Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab
Hilario, A., Sepulveda, J. M., Hernandez-Lain, A., Salvador, E., Koren, L., Manneh, R., Ruano, Y., Perez-Nuñez, A., Lagares, A., Ramos, A.Volume:
19
Langue:
english
Journal:
Clinical and Translational Oncology
DOI:
10.1007/s12094-016-1502-4
Date:
January, 2017
Fichier:
PDF, 814 KB
english, 2017